Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

6.6K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
6.6K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

5.9K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.9K
Cancer Therapies02:49

Cancer Therapies

9.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.6K
Tumor Immunotherapy01:27

Tumor Immunotherapy

1.3K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A pain management dashboard in the neonatal intensive care unit: anticipated barriers and facilitators of implementation among health care professionals.

JBI evidence implementation·2026
Same author

The Influence of Frailty on Pharmacotherapy Adherence and Adverse Drug Reactions in Older Psychiatric Patients.

Geriatrics (Basel, Switzerland)·2025
Same author

Fairy circles and temporal periodic patterns in the delayed plant-sulfide feedback model.

Mathematical biosciences and engineering : MBE·2024
Same author

Mathematical model for IL-2-based cancer immunotherapy.

Mathematical biosciences·2024
Same author

A stochastic framework for evaluating CAR T cell therapy efficacy and variability.

Mathematical biosciences·2024
Same author

Stochastic dynamics of human papillomavirus delineates cervical cancer progression.

Journal of mathematical biology·2023
Same journal

Modeling the impact of budget limitation on the screening and treatment pathway of HPV-induced precancerous cervical lesions.

Mathematical biosciences and engineering : MBE·2026
Same journal

Modeling the effects of trait-mediated dispersal on coexistence of two species: Competition and non-consumptive predator-prey.

Mathematical biosciences and engineering : MBE·2026
Same journal

A close look at the viral reduction rate in target cell limited models.

Mathematical biosciences and engineering : MBE·2026
Same journal

A stochastic agent-based model for simulating tumor-immune dynamics and evaluating therapeutic strategies.

Mathematical biosciences and engineering : MBE·2026
Same journal

Addressing domain shift via imbalance-aware domain adaptation in embryo development assessment.

Mathematical biosciences and engineering : MBE·2026
Same journal

Effect of drug resistance on an HIV epidemic in heterogeneous populations.

Mathematical biosciences and engineering : MBE·2026
See all related articles

Related Experiment Video

Updated: Dec 7, 2025

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

10.0K

Basic stochastic model for tumor virotherapy.

Tuan Anh Phan1, Jianjun Paul Tian1

  • 1Department of Mathematical Sciences, New Mexico State University, Las Cruces, New Mexico, 88001, USA.

Mathematical Biosciences and Engineering : MBE
|September 29, 2020
PubMed
Summary
This summary is machine-generated.

This study introduces a stochastic model for oncolytic virotherapy, revealing parameters that predict tumor eradication. Environmental noise and viral burst size influence treatment success, offering new insights into viral therapy dynamics.

Keywords:
Ito stochastic differential equationergodic invariant probability measureviral burst sizevirotherapy

More Related Videos

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy
08:51

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Published on: April 3, 2018

9.4K
Handling of the Cotton Rat in Studies for the Pre-clinical Evaluation of Oncolytic Viruses
06:13

Handling of the Cotton Rat in Studies for the Pre-clinical Evaluation of Oncolytic Viruses

Published on: November 24, 2014

9.7K

Related Experiment Videos

Last Updated: Dec 7, 2025

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

10.0K
Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy
08:51

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Published on: April 3, 2018

9.4K
Handling of the Cotton Rat in Studies for the Pre-clinical Evaluation of Oncolytic Viruses
06:13

Handling of the Cotton Rat in Studies for the Pre-clinical Evaluation of Oncolytic Viruses

Published on: November 24, 2014

9.7K

Area of Science:

  • Mathematical Biology
  • Oncology
  • Virology

Background:

  • Oncolytic virotherapy offers a promising cancer treatment strategy.
  • Deterministic models simplify complex biological systems, potentially overlooking crucial factors like environmental noise.

Purpose of the Study:

  • To develop and analyze a stochastic model for oncolytic virotherapy incorporating environmental noise and stochastic effects.
  • To identify key parameters and thresholds governing tumor eradication and viral therapy dynamics.

Main Methods:

  • Formulation of a stochastic model using Ito stochastic differential equations.
  • Detailed mathematical analysis employing boundary methods.
  • Numerical simulations to illustrate model behavior and biological implications.

Main Results:

  • Identification of two critical parameters: one for tumor eradication potential and another related to viral burst size.
  • Discovery of thresholds that classify the asymptotic dynamics of the model.
  • Demonstration of three ergodic invariant probability measures corresponding to deterministic model equilibria.
  • Highlighting the potential for tumor eradication influenced by tumor growth rate variance and viral burst size.

Conclusions:

  • The stochastic model provides a more comprehensive understanding of oncolytic virotherapy dynamics.
  • Environmental noise and viral burst size are significant factors influencing treatment outcomes.
  • The identified parameters and thresholds can guide the development and optimization of viral therapies.